InvestorsHub Logo
Followers 0
Posts 18
Boards Moderated 0
Alias Born 10/11/2012

Re: None

Thursday, 11/02/2017 3:46:35 PM

Thursday, November 02, 2017 3:46:35 PM

Post# of 1448
Timeline

Could someone please clarify timeline.

Vancouver, B.C. and Boston, MA,
September 27,2017

Imagin Medical, Inc.
(CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”)announced today that the University of Rochester (UR)Research Study Review Board RSRBhas approved the first in human study using the company’s i/Blue Imaging
System. Recruitment of subjects will begin immediately and continue until the study is completed, which is expected to be a 3-month process. More information can be found on www.clinicaltrials.com.


3-month process for completion of enrollment OR completion of study/trial (December 2018 as per clinicaltrials.gov).

Estimated Enrollment: 10
Anticipated Study Start Date: October 1, 2017
Estimated Study Completion Date: December 1, 2018
Estimated Primary Completion Date: October 1, 2018 (Final data collection date for primary outcome measure)

Thanks